Journey Colab is pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. They plan to build a portfolio of plant-identical compounds. Their first compound in development is mescaline.

Pharmaceutical

Journey Colab

Journey Colab's headquarters in San Francisco, CA, United States

Rebecca Lee

Peter Hendricks

Michael Bogenschutz

The Pharmaceutical Development Team at Journey Colab focuses on formulating, optimizing, and testing psychedelic compounds, including mescaline, to meet FDA regulatory standards for mental health therapies. Their work involves chemical synthesis, preclinical studies, and collaboration with clinical research teams to ensure safety, efficacy, and scalability of the compounds.

Pharmaceutical Development Team

The Leadership Team at Journey Colab drives the strategic vision and operational execution of the company’s mission to develop FDA-approved psychedelic therapies. Comprising the Founder and key executives, the team collaborates on critical decisions regarding research, regulatory compliance, and market strategy, ensuring that innovative plant-identical compounds effectively address mental health challenges and promote community resilience.

Journey Colab

Org chart

Board & advisors

Teams

Pharmaceutical Development Team

Leadership Team

Offices

Journey Colab

Org chart

Board & advisors

Teams

Pharmaceutical Development Team

Leadership Team

Offices

Related companies